13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001590144
Total reported value
$37.0M
$37.0M
40 檔
125.1%
As reported in its official Q3 2024 Form 13F filing, Pura Vida Investments, LLC's tracked investment portfolio stood at $37.0M with 40 total positions.
During Q3 2024, Pura Vida Investments, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MSOS | Advisorshares Pure US Cann | ETF-Other | 7.58% | — | +106.24% | |
| 2 | IHI | Ishares U.s. Medical Devices | ETF-Other | 5.79% | — | — | |
| 3 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 5.76% | — | — | |
| 4 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 5.61% | — | -40.00% | |
| 5 | ✓ | Establishment Labs Holdings In | Stock-Other | 5.41% | -6.73% | -16.58% | |
| 6 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 4.77% | — | -25.00% | |
| 7 | ICUI | Icu Medical Inc | Stock-Other | 4.45% | — | +27.84% | |
| 8 | COO | Cooper Cos Inc/the | Stock-Healthcare | 4.31% | — | +100.00% | |
| 9 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 4.13% | — | — | |
| 10 | WAT | Waters CORP | Stock-Healthcare | 4.10% | — | — | |
| 11 | GKOS | Glaukos CORP | Stock-Healthcare | 3.74% | — | -49.43% | |
| 12 | NTRA | Natera Inc | Stock-Healthcare | 3.60% | -2.26% | -35.56% | |
| 13 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 3.27% | — | -46.03% | |
| 14 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 3.22% | — | — | |
| 15 | ZBH | Zimmer Biomet Holdings Inc | Stock-Healthcare | 3.17% | — | — | |
| 16 | QTRX | Quanterix CORP | Stock-Other | 2.96% | — | -14.32% | |
| 17 | LUNG | Pulmonx CORP | Stock-Other | 2.75% | — | -0.62% | |
| 18 | BVS | Bioventus Inc - A | Stock-Other | 2.75% | — | +25.92% | |
| 19 | ZTS | Zoetis Inc | Stock-Healthcare | 2.55% | — | — | |
| 20 | MDT | Medtronic plc | Stock-Healthcare | 2.35% | — | +33.33% | |
| 21 | SYK | Stryker CORP | Stock-Healthcare | 2.12% | — | — | |
| 22 | CSTL | Castle Biosciences Inc | Stock-Other | 2.10% | — | -26.42% | |
| 23 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.73% | — | — | |
| 24 | GH | Guardant Health Inc | Stock-Healthcare | 1.72% | — | +15.00% | |
| 25 | PRCT | Procept Biorobotics CORP | Stock-Other | 1.31% | — | — | |
| 26 | ARKG | Ark Genomic Revolution ETF | ETF-Other | 1.25% | — | -34.78% | |
| 27 | ELAN | Elanco Animal Health Inc | Stock-Healthcare | 0.96% | — | +76.67% | |
| 28 | IMDX | Insight Molecular Diagnostic | Stock-Other | 0.92% | -13.15% | — | |
| 29 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 0.83% | — | -25.93% | |
| 30 | BRKR | Bruker CORP | Stock-Healthcare | 0.81% | — | -44.62% | |
| 31 | NSPR | Inspiremd Inc | Stock-Other | 0.79% | -4.09% | — | |
| 32 | BAX | Baxter International Inc | Stock-Healthcare | 0.74% | — | — | |
| 33 | INMD | InMode Ltd. | Stock-Other | 0.66% | — | — | |
| 34 | CUTREUR | Cutera Inc | Stock-Other | 0.60% | — | -0.03% | |
| 35 | MGX | Metagenomi Therapeutics Inc | Stock-Other | 0.38% | -1.53% | — | |
| 36 | MMM | 3m Co | Stock-Industrials | 0.36% | — | — | |
| 37 | ZIMV | Zimvie Inc | Stock-Other | 0.24% | — | -67.14% | |
| 38 | DCGO | Docgo Inc | Stock-Other | 0.22% | — | — | |
| 39 | TALKW | Hudson Executive Inv -cw25 | Stock-Other | 0.01% | — | — | |
| 40 | ✓ | Wm Technology Inc | Stock-Other | — | — | — |
According to official SEC Form 13F filings, Pura Vida Investments, LLC reported a total U.S. public equity portfolio value of $37.0M across 40 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including MSOS, IHI, IWM) accounted for 125.1% of total reported equity market value during Q3 2024.
During Q3 2024, Pura Vida Investments, LLC's top holdings by market value included MSOS (7.6%)、IHI (5.8%)、IWM (5.8%). The largest single position, MSOS, represented 7.6% of total portfolio value.
In Q3 2024, Pura Vida Investments, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.